Veldmar Therapeutics Ltd.
TSXV: VLDMPre-revenue oncology developer. Shares auditor and a scientific officer with Cascade BioSciences. Recently filed a bought-deal financing.
Insider trades
2 reported trades by directors and officers of Veldmar Therapeutics Ltd..
Buy volume
$102,000
Sell volume
$0
Net flow
$102,000
| Insider | Action | Shares | Price | Value | Trade date | Reported |
|---|---|---|---|---|---|---|
Noor Haddad, M.D. CEO | Buy | 40,000 | $2.55 | $102,000 | Jun 19, 2026 | 27d ago |
Julien Arsenault CFO | Option Exercise | 25,000 | $1.40 | $35,000 | May 25, 2026 | 1mo ago |